On this page
Mark Gross
Insider
First SEC filing: Dec. 26, 2023 · Latest: Dec. 26, 2023
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net: $0
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| June 20, 2025 | RXT | A | 75,471 | · | · | 168,095 Direct | +81.48% | Acquired | (price as of 2026-10-02) |
| June 24, 2024 | RXT | A | 51,948 | · | · | 92,624 Direct | +127.71% | Acquired | (price as of 2026-10-02) |
| Feb. 13, 2024 | RXT | A | 40,676 | · | · | 40,676 Direct | · | Acquired | (price as of 2026-10-02) |
| Dec. 24, 2023 | DBD | A | 80,000 | · | · | 80,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Dec. 24, 2023 | DBD | A | 40,000 | · | · | 40,000 Direct | · | Acquired | (price as of 2026-10-02) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Dec. 24, 2023 | DBD | Director Stock Option (right to buy) | Common Stock | $30.00 | Dec. 24, 2028 | 80,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).